Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?

Date
2021
Author
YUMUK, Volkan Demirhan
Siva, Zeynep Osar
Sahin, Humeyra Rekali
DAMCI, Taner
Ilkova, Hasan
Sahin, Serdar
Haliloglu, Ozlem
Korkmaz, Ozge Polat
DURCAN, Emre
Metadata
Show full item record
Abstract
Background/aim: To evaluate the impact of treatment with sodium-glucose co-transporter-2 (SGLT2) Inhibitors on quality of life (QoL), sleep quality (SQ), and anxiety levels in patients with Type 2 diabetes mellitus (T2DM).
URI
http://hdl.handle.net/20.500.12627/171632
https://doi.org/10.3906/sag-2008-37
Collections